E4 HCPCS Level II modifier: Lower right, eyelid
E4 is a HCPCS Level II modifier: “Lower right, eyelid.” It adds this detail to the code it is reported with.
Official description
E4Lower right, eyelid
Short description: Lower right eyelid
HCPCS · United States
Medicare details
The indicators CMS publishes with E4 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Added
- Jan 1, 1995
Where E4 sits
- 1GroupHCPCS modifiers
- 2Modifier E4Lower right, eyelid
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code E4 mean?
E4 is the HCPCS code for “Lower right, eyelid” in CMS’s HCPCS Level II October 2026 release.
Where is E4 in the HCPCS Level II list?
E4 is listed under Modifiers.
Does Medicare cover E4?
CMS lists E4’s Medicare coverage as “Carrier judgment”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside E4
All modifiersCSCost-sharing waived for specified covid-19 testing-related services that result in and order for or administration of a covid-19 test and/or used for cost-sharing waived…CTComputed tomography services furnished using equipment that does not meet each of the attributes of the national electrical manufacturers association (nema) xr-29-2013 standardDAOral health assessment by a licensed health professional other than a dentistE1Upper left, eyelidE2Lower left, eyelidE3Upper right, eyelidEAErythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer chemotherapyEBErythropoietic stimulating agent (esa) administered to treat anemia due to anti-cancer radiotherapyECErythropoietic stimulating agent (esa) administered to treat anemia not due to anti-cancer radiotherapy or anti-cancer chemotherapyEDHematocrit level has exceeded 39% (or hemoglobin level has exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycleEEHematocrit level has not exceeded 39% (or hemoglobin level has not exceeded 13.0 g/dl) for 3 or more consecutive billing cycles immediately prior to and including the current cycleEJSubsequent claims for a defined course of therapy, e.g., epo, sodium hyaluronate, infliximab